Elevated IL-6 serum levels strongly correlate with increased risk to develop HCC and vice versa; serum IL-6 and sIL-6Rα levels are elevated in patients suffering from HCC [120,121,122,123]. This evidence concerns the gene IL6 and hepatocellular carcinoma.